Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction-Reference-Cited by-同舟云学术

Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction

Published:2016-09-08 Issue:42 Volume:7 Page:68650-68661
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mathew Stephen O.¹,Chaudhary Pankaj²,Powers Sheila B.¹,Vishwanatha Jamboor K.²,Mathew Porunelloor A.¹

Affiliation:

1. Department of Cell Biology and Immunology and Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA

2. Department of Molecular and Medical Genetics and Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive pan-cancer analysis of KLRB1-CLEC2D pair and identification of small molecule inhibitors to disrupt their interaction;International Immunopharmacology;2024-10

2. Challenges of targeting tumor microenvironment in prostate cancer;New Updates in Tumor Microenvironment [Working Title];2024-08-14

3. Transcriptional switches in melanoma T Cells: Facilitating polarizing into regulatory T cells;International Immunopharmacology;2024-08

4. Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis;Journal of Neuro-Oncology;2024-06-22

5. Association of CIITA (rs8048002) and CLEC2D (rs2114870) gene variants and type 1 diabetes mellitus;Journal of Diabetes & Metabolic Disorders;2024-04-18